Lung Cancer Drugs Market Research Reports

From
Drug Overview: Tecentriq - Product Thumbnail Image

Drug Overview: Tecentriq

  • Drug Pipelines
  • 82 Pages
From
Drug analysis: Opdivo - Product Thumbnail Image

Drug analysis: Opdivo

  • Drug Pipelines
  • 103 Pages
From
Drug analysis: Cyramza - Product Thumbnail Image

Drug analysis: Cyramza

  • Drug Pipelines
  • 56 Pages
From
Drug Analysis: Gilotrif - Product Thumbnail Image

Drug Analysis: Gilotrif

  • Drug Pipelines
  • 31 Pages
From
Drug analysis: Avastin - Product Thumbnail Image

Drug analysis: Avastin

  • Drug Pipelines
  • 116 Pages
From
From
Loading Indicator

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more

adroll